Outcomes of beta blockers (BB) in hepatocellular carcinoma (HCC) treated with immune checkpoint inhibitors (ICIs)

被引：0
|
作者：
Wu, Linda
Ozbek, Umut
van Hyfte, Grace
Reincke, Marlene
Gampa, Anuhya
Abugabal, Yehia I.
Nishida, Naoshi
Wietharn, Brooke
Amara, Suneetha
Balcar, Lorenz
Pinter, Matthias
Vogel, Arndt
Weinmann, Arndt
Saeed, Anwaar
Rimassa, Lorenza
Naqash, Abdul Rafeh
Muzaffar, Mahvish
Huang, Yi-Hsiang
Pinato, David James
Ang, Celina
机构：
[1] Mt Sinai Hosp, Tisch Canc Inst, New York, NY 10029 USA
[2] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[3] Mt Sinai Hosp, New York, NY 10029 USA
[4] Univ Freiburg, Fac Med, Med Ctr, Freiburg, Germany
[5] Univ Chicago, Med Ctr, Chicago, IL 60637 USA
[6] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[7] Kindai Univ, Osaka, Japan
[8] Univ Kansas, Sch Med, Kansas City, KS USA
[9] East Carolina Univ, Greenville, NC 27858 USA
[10] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Vienna, Austria
[11] Med Univ Vienna, Vienna, Austria
[12] Hannover Med Sch, Hannover, Germany
[13] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Mainz, Germany
[14] Kansas Univ, Canc Ctr, Kansas City, KS USA
[15] Humanitas Univ, Pieve Emanuele & Humanitas Canc Ctr, IRCCS Humanitas Res Hosp, Dept Biomed Sci, Milan, Italy
[16] NCI, Dev Therapeut Clin, Early Clin Trials Dev Program, Div Canc Treatment & Diag, Bethesda, MD 20892 USA
[17] East Carolina Univ, Vidant Canc Ctr, Greenville, NC 27858 USA
[18] Natl Yang Ming Univ, Taipei Vet Gen Hosp, Inst Clin Med, Div Gastroenterol & Hepatol, Taipei, Taiwan
[19] Imperial Coll, Dept Surg & Canc, London, England
[20] Mt Sinai Hosp, Tisch Canc Inst, Dept Med, Div Hematol Oncol, New York, NY 10029 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 04期
关键词：
D O I：
10.1200/JCO.2022.40.4_suppl.399
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
399
引用
收藏
页数：3
相关论文
共 50 条
  • [31] The impact of beta blockers on survival outcomes in non-small cell lung cancer patients treated with immune checkpoint inhibitors
    Oh, Michael
    Oh, Michael
    Guzner, Alex
    Wainwright, Derek
    Mohindra, Nisha
    Chae, Young Kwang
    Behdad, Amir
    Villaflor, Victoria
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [32] Inflammatory markers to predict prognosis in renal cell carcinoma (RCC) patients treated with immune checkpoint inhibitors (ICIs)
    Carril, Lucia
    De Liano Lista, Alfonso Gomez
    Pozas, Javier
    Gordoa, Teresa Alonso
    Bernardini, Alejandra
    Carretero-Gonzalez, Alberto
    Martin Soberon, Maria Cruz
    Sepulveda Sanchez, Juan Manuel Manuel
    Paramio, Jesus
    Castellano, Daniel
    De Velasco, Guillermo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [33] The Impact of Beta Blockers on Survival Outcomes in Patients With Non-small-cell Lung Cancer Treated With Immune Checkpoint Inhibitors
    Oh, Michael S.
    Guzner, Alex
    Wainwright, Derek A.
    Mohindra, Nisha A.
    Chae, Young K.
    Behdad, Amir
    Villaflor, Victoria M.
    [J]. CLINICAL LUNG CANCER, 2021, 22 (01) : E57 - E62
  • [34] Potential roles of gut microbiome in patients with hepatocellular carcinoma treated with immune checkpoint inhibitors
    Su, Yung-Yeh
    Lee, Wei-Hsiang
    Wang, Jing-Houng
    Wang, Hung-Wei
    Chen, Teng-Wei
    Chen, Bang-Bin
    Ho, Hsiu J.
    Liu, Tsung-Hao
    Chou, Shu-Cheng
    Chen, Bor-Rong
    Liu, Tsang-Wu
    Chen, Li-Tzong
    Wu, Chun-Ying
    Hsu, Chiun
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S484 - S484
  • [35] Impact of underlying liver disease on unresectable hepatocellular carcinoma treated with immune checkpoint inhibitors
    Y. Linda Wu
    Sarah Cappuyns
    Amanda Loh
    Sean Sun
    Sara Lewis
    Max W. Sung
    Myron Schwartz
    Josep M. Llovet
    Deirdre J. Cohen
    [J]. BJC Reports, 2 (1):
  • [36] Emerging immune checkpoint inhibitors for the treatment of hepatocellular carcinoma
    Chan, Landon L.
    Chan, Stephen L.
    [J]. EXPERT OPINION ON EMERGING DRUGS, 2021, 26 (01) : 39 - 51
  • [37] Unraveling the Complexities of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
    Han, Xinpu
    Sun, Qianhui
    Xu, Manman
    Zhu, Guanghui
    Gao, Ruike
    Ni, Baoyi
    Li, Jie
    [J]. SEMINARS IN LIVER DISEASE, 2023, 43 (04) : 383 - 401
  • [38] Hepatocellular carcinoma and immunotherapy: Beyond immune checkpoint inhibitors
    Hassan Mohammed Abushukair
    Anwaar Saeed
    [J]. World Journal of Gastrointestinal Oncology, 2022, 14 (06) : 1210 - 1212
  • [39] Clinical Trials of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
    Dyhl-Polk, Anne
    Mikkelsen, Marta Kramer
    Ladekarl, Morten
    Nielsen, Dorte Lisbet
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (12)
  • [40] Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Opportunities and Challenges
    Liu, Xiufeng
    Qin, Shukui
    [J]. ONCOLOGIST, 2019, 24 : S3 - S10
12345